GL1X · GenesisL1 explorer

Research workbench

Human TNKS1 in complex with 6,8-difluoro-2-[4-(1-hydroxy-1-methyl- ethyl)-phenyl]-3H-quinazolin-4-one

Analyse Human TNKS1 in complex with 6,8-difluoro-2-[4-(1-hydroxy-1-methyl… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6QXU
Type
protein
Length
209 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase tankyrase-1
EC
2.4.2.30, 2.4.2.-
UniProt
O95271
Ligands
JKN, ZN
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase tankyrase-1 (EC 2.4.2.30, 2.4.2.-)protein20924% helix, 29% strandO95271

Ligands and binding sites

  • JKN · 6,8-bis(fluoranyl)-2-[4-(2-oxidanylpropan-2-yl)phenyl]-3~{H}-quinazolin-4-one · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • BME · Beta-mercaptoethanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13240.620.7938JKN

Modifications

Observed in the structure: 1 covalent (additive adduct).

Compared structures

  • 6QXU · Human TNKS1 in complex with 6,8-Difluoro-2-[4-(1-hydroxy-1-methyl-ethyl)-phenyl]-3H-quinaz… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.